Fresh analysis indicates that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle programs.
Findings released in a leading medical journal demonstrates that while overweight people often shed a large proportion of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month after stopping.
"Individuals buying these medications must be informed of the danger of rapid weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
This pace of regain means a reversion to starting weight within about a year and a half.
Weighing Treatments
The analysis, which looked at 37 of trials involving thousands of participants, compared the results of GLP-1 agonists with other pills.
Researchers emphasize that people who lose weight through dieting usually have a more gradual weight regain—approximately 0.1 kg a month—after stopping.
The Reason for the Rapid Regain
Doctors suggest the way of the injections accounts for the amplified regain.
These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its own natural hormone, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication means hunger is uncontrolled, making overeating much more probable."
A Lifelong Disease?
The NHS recommend the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts argue that, given the high risk of weight regain, the treatment might need to be life-long.
This perspective is echoed by pharmaceutical companies, who say that the results "underscore the long-term character of obesity," akin to managing conditions like diabetes.
Patient Testimonies
Users who have come off the medication explain a powerful return of hunger.
"I experienced something that goes on and you're instantly starving," said one woman.
This difficulty is exacerbated if users have not developed permanent lifestyle or habit changes during treatment.
Growing Use
Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.
- Adoption is greater among women compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
Ultimately, clinicians stress that while these medications are powerful tools for weight loss, they are not a magic cure and long-term success hinges on integrated lifestyle support.
